Class IITerminatedD-0952-2023
Drug recall · August 9, 2023
glycopyrrolate 1 mg/5 mL recall
Why: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1
- Lots / codes
Lot: 36-247022, Exp 08/07/2023; 36-239877, Exp 07/13/2023; 36-241448, Exp 07/20/2023; 36-251782, Exp 08/29/2023
- Quantity
- 770 Syringes
- Company
- Central Admixture Pharmacy Services, Inc., Phoenix, AZ
- Distribution
- Nationwide in the USA
- Initiated
- July 14, 2023 · Voluntary: Firm initiated
- Classified
- August 1, 2023
- Reported
- August 9, 2023
- Ended
- March 28, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedAug 9, 2023rocuronium50 mg/5 mLCentral Admixture Pharmacy Services, Inc. · D-0947-2023Class IITerminatedAug 9, 2023vancomycin 1 g/250 mL added to 0.9% sodium chlorideCentral Admixture Pharmacy Services, Inc. · D-0948-2023Class IITerminatedAug 9, 2023succinylcholine 200 mg/10 mLCentral Admixture Pharmacy Services, Inc. · D-0949-2023Class IITerminatedAug 9, 2023vancomycin 1.25 g/250 mL added to dextrose 5%Central Admixture Pharmacy Services, Inc. · D-0950-2023Class IITerminatedAug 9, 2023dilTIAZem 125mg/125mLCentral Admixture Pharmacy Services, Inc. · D-0951-2023Class IITerminatedAug 9, 2023dilTIAZem 125mg/125mLCentral Admixture Pharmacy Services, Inc. · D-0953-2023Class IITerminatedAug 9, 2023EPINEPHrine 4mg/250mL added to 0.9% sodium chlorideCentral Admixture Pharmacy Services, Inc. · D-0954-2023Class IITerminatedAug 9, 2023vancomycin 1.25 g/250 mL added to 0.9% Sodium ChlorideCentral Admixture Pharmacy Services, Inc. · D-0955-2023Class IITerminatedAug 9, 2023Cardioplegia Solution del Nido FormulaCentral Admixture Pharmacy Services, Inc. · D-0956-2023Class IITerminatedAug 9, 2023EPINEPHrineCentral Admixture Pharmacy Services, Inc. · D-0957-2023Class IITerminatedAug 9, 2023EPINEPHrine added to dextrose 5%Central Admixture Pharmacy Services, Inc. · D-0958-2023Class IITerminatedAug 9, 2023EPINEPHrine 8mg/250ml added to dextrose 5%Central Admixture Pharmacy Services, Inc. · D-0959-2023
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.